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Abstract.  
The objective of the research was to identify volumetric brain indicators (hippocampal volume) in patients with 
chronic cerebral ischemia secondary to metabolic syndrome (MS) in comparison with patients suffering from chronic 
cerebral ischemia without MS; to identify the hippocampal index as well as medial, lateral and upper perihippocampal 
indices in patients with MS in comparison with those in patients without MS.  
Materials and methods. Hippocampal volume of 47 patients (29 patients with MS - the main group and 18 
patients without MS – the control group) was evaluated by means of volumetric method. During 49 studies (28 - the main 
group and 21 - the control group) the size of the hippocampus and perihippocampal cerebrospinal fluid space was 
measured.  
Results and discussion. We determined a significant increase (*p<0.05 in comparison with the control group) 
зin the lateral perihippocampal cerebrospinal fluid space (cm) in the main group in comparison with the control group 
(Me [Q1, Q3]): on the right it was 2.90 [2.75 ; 2.96]  vs. 2.21 [1.82; 2.05] in the control group (р<0.05); on the left it was 
2.97 [2.75; 2.96] vs. 2.275 [2.15; 2.76] in the control group (р>0.05). A significant decrease in the index of the right and 
left hippocampus was determined in patients with MS in comparison to the patients of the control group (Me [Q1,Q3]): 
on the right it was 0.50 [0.41; 0.54] vs. 0.594 [0.58; 0.61]; on the left it was 0.56 [0.52; 0.60] vs. 0.61 [0.58; 0.63] in the 
control group (р<0.05). A significant difference in the increase of the medial and upper perihippocampal indices on either 
side was defined in the main group in comparison with the control one. Lateral perihippocampal index did not 
significantly differ from the control group (р>0.05). Determination of the hippocampal volume (right and left) showed 
that it was significantly lower in patients with MS than in patients without MS (Me [Q1,Q3]): on the right it was 3.293058* 
[2.92616; 3.04016] in the main group, and 3.93 [3.72750; 4.29722] in the control group; on the left it was 2.84 [2.65; 
3.02] * in the main group, and 3.55 [3.22, 3.7] in the control group. Components of MS cluster in patients with chronic 
cerebrovascular pathology are likely to contribute to the development of atrophic processes. The combination of 
hypertension, insulin resistance, dyslipidemia, etc. accelerate the processes of hippocampal atrophy more than each of 
these separate components determined in patients with chronic cerebral ischemia without MS.  
Conclusions. Thus, the degree of hippocampal atrophy in patients with chronic cerebrovascular diseases 
secondary to MS was defined to be significantly higher in comparison with patients without MS. To improve diagnosis 
of cerebrovascular diseases in patients with MS, it is possible to apply the identification of the hippocampal index and 
perihippocampal indices if it is not possible to determine the volume of brain structures.  
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Problem statement and analysis of the recent research  
High disability progression, increase in human mortality, as well as increased number of young people in the 
structure of brain ischemia and the progression of cognitive impairments spike the interest in the problems of diagnosis, 
treatment and prevention of cerebrovascular diseases. 
According to the results of a recent study on stroke performed in the USA (Greater Cincinnati/Northern Kentucky 
Stroke Study–GCNKSS), in the community numbering1.3 million people at the age of 20-54 years, the rate of patients 
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to 69 years in 2005 being 71 in 1993-1994. Probable explanation of this fact may be the change in demographic 
characteristics of causative risk factors for developing stroke - for example, increased obesity among children and young 
adults, sedentary lifestyle and unhealthy diet which can result in premature development of cerebrovascular diseases due 
to high blood pressure and the development of diabetes. According to the results of the National Health and Nutrition 
Examination Survey (NHANES) designed to assess the health and nutritional status of adults and children in the United 
States prevalence of risk factors for stroke among adults at the age of 20-54 years was almost double: prevalence of 
diabetes increased from 2% in 1988-1994 to 4% in 2005-2006, high blood cholesterol level increased from 11% to 21%, 
obesity increased from 19% to 34%. In this regard, metabolic syndrome problem including hypertension, insulin 
resistance, visceral obesity, hypercholesterolemia and diabetes mellitus takes centre stage.  
Cardiac, neurological and endocrinological diseases resulting from metabolic syndrome cause mortality, disability 
and dramatic decrease in quality of lifestyle. Scientists and doctors’ interest spike in the metabolic syndrome during the 
last decades is associated with the importance of preventing type 2 diabetes and cardiovascular diseases due to 
atherosclerosis. Metabolic syndrome prevalence increases annually. Nowadays the WHO experts consider this situation 
to be a new pandemic of the XXI century spanning industrialized countries. 
The most significant argument for studying the impact of MS on the occurrence, clinical manifestations and 
prognosis of ischemic stroke is its atherogenic potential of cardiac and cerebrovascular complications due to 
atherosclerosis. Many studies have shown that patients with MS often develop early signs of carotid and coronary arteries 
atherosclerosis. It indicates that the causes of myocardial infarction, ischemic stroke and peripheral vascular diseases have 
a common origin. Thus, the studies [5, 6, 2] showed that treatment regimens do not only prevent coronary conditions and 
the need for revascularization, but also reduce the incidence of ischemic stroke and peripheral vascular diseases.  
It is considered that pathogenesis of chronic cerebral ischemia results from increase in pathobiochemical 
abnormalities caused by decreased levels of oxygen in arterial blood (hypoxemia) on the one hand and the influence of 
suboxide oxygen intermediates (oxidative stress) on the other hand. As a result, patients with chronic cerebral ischemia 
having chronic disorders of cerebral perfusion, systemic blood flow, microcirculation and hypoxemia develop micro-
lacunar ischemic zones. Chronic brain hypoperfusion causes changes primarily in white matter forming foci of 
demyelination damaging astro- and oligodendroglia with microcapillary compression and results in apoptotic foci. These 
pathologic processes in chronic cerebral ischemia result in clinical changes manifested as both subjective and objective 
symptoms occurring due to disorders of cortico-striate and cortico-stem connections. The clinical picture of chronic 
cerebral ischemia is manifested by a combination of cognitive disorders, emotional disorders and focal neurological 
symptoms, the character of which is mostly determined by localization of changes in brain substance and their severity 
[4]. One of the severest manifestations of chronic cerebral ischemia is vascular dementia [1].  
Regarding the occurrence of cognitive impairment in patients with MS, there are disputable points of view 
presented in scientific literature. Several authors associate MS with decline in cognitive function and developing dementia 
of neurodegenerative and vascular origin. The studies revealed connection of dementia with hypertension, diabetes and 
metabolic syndrome. It was determined that patients with prediabetes, hyperinsulinemia, metabolic syndrome with 
hypertension, dyslipidemia and obesity have worse cognitive capabilities and they reduce faster [7, 8]. Even MS itself 
without diabetes contributes to the development of Alzheimer’s disease [3, 9]. 
Characteristic morphometric changes according to brain MRI and CT occur in acute cerebrovascular accidents 
and other organic damages, which reveal features specific to a particular process. MRI does not usually reveal any 
pathological changes caused by chronic ischemia. The significance of microfocal changes has not been cleared out yet. 
According to the published data, they can comply with natural brain aging and are common to most people over 65 years 
old. Structural brain damage in patients with chronic cerebral ischemia affected by MS has been insufficiently studied 
and existing data are disputable. 
The objective of the research was to identify volumetric brain indicators (hippocampus) in patients with chronic 
cerebral ischemia affected by MS and compare them to those of the patients with chronic cerebral ischemia without MS; 
to identify the hippocampal index as well as medial, lateral and upper perihippocampal indices in patients with MS in 
comparison with those in patients without MS. 
Materials and methods 
Hippocampal volume of 47 patients (29 patients with MS - the main group and 18 patients without MS – the 
control group) was evaluated by means of volumetric method (measuring volume of brain structures) using the Toshiba 
Vantage Titan 1.5T MRI machine. The Vitrea workstation was used for image post-processing. We used MR sequences: 
T1 - weighted image, T2- weighted images, Isotropic, Flair, DWI, T2*, FSBB. The volume of the right and left 
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The research of the volume of certain brain structures is a complex, time-consuming process and requires long-
term patient’s exposure to the MRI scanning. The literature describes a technique proposed by Scheltens et al, based on 
the assessment of the medial temporal lobe, including the hippocampus, and the volume of the cerebrospinal fluid space, 
in particular, temporal horn of the lateral ventricle and vascular slit [10]. According to this method the study (MRI) of the 
brain was performed by means of Siemens MAGNETOM Avanto 1.5Tl MRI Scanner. T2WI, T2blade dark-fl, T1WI 
scans of the brain were performed in axial, coronal and sagittal projections. In 49 patients (28 patients of the main group 
and 21 patients of the control group) transverse and vertical size of the hippocampus, transverse and vertical size of the 
whole perihippocampal cerebrospinal fluid space and transverse size of the medial, lateral (temporal horn) and vertical 
perihippocampal spaces were measured. Both right and left hemispheres were measured. Then the hippocampal index 
was calculated; set of transverse and vertical diameters of the hippocampus was divided by the plurality of transverse and 
vertical diameters of the whole perihippocampal space (Fig.1).The medial perihippocampal index was calculated in the 
following way: the width of the medial cerebrospinal fluid space was divided by the full-width of perihippocampal 
cerebrospinal fluid space. The lateral perihippocampal index was calculated in the following way: the width of the lateral 
cerebrospinal fluid space was divided by the full-width of perihippocampal cerebrospinal fluid space. The superior 
perihippocampal index was calculated in the following way: the height of the outer cerebrospinal fluid space was divided 




Fig.1. Transverse and vertical size of the hippocampus (on the left) and transverse and vertical size of the whole 
perihippocampal cerebrospinal fluid space (on the right) 
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Fig.2. Measuring the size of the medial cerebrospinal fluid space 
Fig.3. Measure the size of the outer cerebrospinal fluid space 
Fig.4. Measuring the size of the lateral cerebrospinal fluid space 
 
Results and discussion 
While measuring the size of the transverse perihippocampal cerebrospinal fluid space (cm), a significant increase 
(* p < 0.05 in comparison with the control group) in this index was determined in the main group in comparison with the 
control group (Me [Q1, Q3]): on the right it was 2.90 [2.75 ; 2.96]  vs. 2.21 [1.82; 2.05] in the control group; on the left 
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Table 1 
Hippocampal index in patients with chronic cerebrovascular pathology 
 Main Group Control Group 
Me [Q1,Q3] Me [Q1,Q3] 
right left right left 
Hippocampal index 0.50[0.41;0.54]* 0.56[0.52;0.60]* 0.594[0.58;0.61] 0.61[0.58;0.63] 
Note: *p<0.05 
 
In patients with metabolic syndrome a significant decrease in the hippocampal index (right and left) in comparison 
with the control group was determined. 
 
Table 2 
Lateral, medial and upper perihippocampal indices 
 Main Group Control Group 
Me [Q1,Q3] Me [Q1,Q3] 
right left right left 
Medial  perihippocampal  
index 
0.18[0.14;0.17]* 0.15[2.75;2.96]* 0.12[2.75;2.96] 0.11[2.75;2.96] 
Lateral perihippocampal  
index 









A significant increase in medial and superior perihippocampal indices both left and right, was defined in the main 
group in comparison with the control group (right and left). The lateral perihippocampal index did not significantly differ 
from that in the control group (p>0.05). 
Thus, patients with chronic cerebrovascular pathology secondary to MS, showed higher rate of hippocampal 
atrophy, which was determined by significant increase in perihippocampal indices and decrease in the hippocampal index 
in comparison with patients without MS.  
The results of measuring the hippocampal volume proved that hippocampal volume (right and left) in patients with 
MS was significantly lower in comparison with that in patients without MS (Table 3). 
 
 Table 3 
Hippocampal volume (left and right) (cm³) 
 Hippocampal volume (cm³) main group Hippocampal volume (cm3) control group 





2.92616 3.04016 3.3692 4.400 3.93 3.72750 4.29722 
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Fig. 6. Measurement of ventricular and hippocampal volume in 62-year-old female patient S., (the main group) - severe 
hippocampal atrophy. 
Fig. 7. Measurement of ventricular and hippocampal volume 64-year-old male patient P., (the control group). 
 
Conclusions 
Thus, the degree of hippocampal atrophy in patients with chronic cerebrovascular diseases secondary to MS was 
defined to be significantly higher in comparison with patients without MS. To improve diagnosis of cerebrovascular 
diseases in patients with MS, it is possible to apply the identification of the hippocampal index and perihippocampal 
indices if it is not possible to determine the volume of brain structures. 
 
Prospects for further research 
The obtained results of the study require further research. It is reasonable to conduct measurements of other 
essential brain structures in patients suffering from CVD secondary to MS and those not affected with MS, and determine 
possible correlation between indices of their volume and cognitive and affective disorders. 
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